Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
18.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
7.42
|
7.55
|
7.28
|
7.24
|
8.2875
|
7.49
|
|
|
35 676 474.98
|
27 699.00
|
6.94
|
7.11
|
6.83
|
6.69
|
7.195
|
7.06
|
|
|
13 630 289.74
|
15 101.00
|
6.80
|
7.20
|
7.09
|
6.79
|
7.35
|
6.82
|
|
|
72 638 033.13
|
17 044.00
|
6.82
|
7.00
|
6.51
|
6.30
|
7.13
|
6.98
|
|
|
14 159 047.16
|
14 045.00
|
6.53
|
6.59
|
6.83
|
6.285
|
7.1799
|
6.56
|
|
|
15 469 481.41
|
15 893.00
|
6.78
|
7.10
|
6.80
|
6.55
|
7.005
|
6.89
|
|
|
10 704 977.11
|
10 491.00
|
6.63
|
6.79
|
6.48
|
6.28
|
6.97
|
6.77
|
|
|
9 477 076.05
|
10 896.00
|
6.37
|
6.50
|
6.54
|
6.36
|
6.92
|
6.52
|
|
|
23 155 624.63
|
11 382.00
|
6.48
|
6.54
|
6.23
|
6.11
|
6.73
|
6.47
|
|
|
15 848 633.20
|
13 162.00
|
5.98
|
6.07
|
5.92
|
5.86
|
6.24
|
6.06
|
|
|
7 498 644.16
|
9 269.00
|
Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. The Company operates in two divisions: BioDefense Division and BioSciences Division. It derived substantially all of its product revenues from sales of BioThrax to the United States government, specifically and the United States Department of Health and Human Services (HHS), as well as the United States Department of Defense (DoD).